Risk and outcome of non‐Hodgkin lymphoma among classical Hodgkin lymphoma survivors
Open Access
Abstract
BACKGROUND: Survivors of classical Hodgkin lymphoma (cHL) are at an increased risk of developing secondary non‐Hodgkin lymphomas (sNHLs). To the authors' knowledge, the outcome of patients with sNHL compared with their de novo counterparts (dnNHL) is unknown.METHODS: Data from 26,826 cases of HL from the Surveillance, Epidemiology, and End Results (SEER) program that were diagnosed between 1992 and 2009 were used to obtain the risk of further development of different subtypes of sNHL. The survival of patients with sNHL was compared with that of matched patients with dnNHL.RESULTS: The estimated cumulative incidence of sNHL was 2.50% (95% confidence interval [95% CI], 2.10‐2.89) at 15 years from the diagnosis of cHL. The standardized incidence ratio was 10.5 (95% CI, 8.9‐12.4) for aggressive B‐cell NHL, 4.0 (95% CI, 3.1‐5.1) for indolent B‐cell NHL, and 14.6 (95% CI, 10.3‐20.1) for T‐cell NHL. Patients with indolent B‐cell sNHL had a worse overall survival compared with their dnNHL counterparts (hazards ratio [HR] of death, 2.7; 95% CI, 1.3‐5.7). Survival was not significantly different between patients with sNHL and those with dnNHL with regard to aggressive B‐cell NHL (HR, 1.3; 95% CI, 0.6‐2.7) or T‐cell NHL (HR, 0.8; 95% CI, 0.3‐1.8).CONCLUSIONS: The risk of developing sNHL after cHL is substantial. Although patients with indolent B‐cell sNHL have inferior survival, patients with aggressive B‐cell sNHL and T‐cell sNHL have survival comparable to that of their de novo counterparts. Cancer 2013;119:3385–92. © 2013 American Cancer Society.Keywords
This publication has 21 references indexed in Scilit:
- Progress in Hodgkin lymphoma: a population-based study on patients diagnosed in Sweden from 1973-2009Blood, 2012
- Second Cancer Risk After Chemotherapy for Hodgkin's Lymphoma: A Collaborative British Cohort StudyJournal of Clinical Oncology, 2011
- Survival after second primary lung cancerCancer, 2011
- Long-Term Survival Among Patients With Hodgkin's Lymphoma Who Developed Breast Cancer: A Population-Based StudyJournal of Clinical Oncology, 2010
- Survival after Hodgkin lymphomaCancer, 2009
- Long-Term Solid Cancer Risk Among 5-Year Survivors of Hodgkin's LymphomaJournal of Clinical Oncology, 2007
- Acute Myeloid Leukemia Following Hodgkin Lymphoma: A Population-Based Study of 35 511 PatientsJNCI: Journal of the National Cancer Institute, 2006
- High Risk of Subsequent Neoplasms Continues With Extended Follow-Up of Childhood Hodgkin’s Disease: Report From the Late Effects Study GroupJournal of Clinical Oncology, 2003
- Second Malignant Neoplasms Among Long-Term Survivors of Hodgkin’s Disease: A Population-Based Evaluation Over 25 YearsJournal of Clinical Oncology, 2002
- Long-Term Survival and Competing Causes of Death in Patients With Early-Stage Hodgkin’s Disease Treated at Age 50 or YoungerJournal of Clinical Oncology, 2002